Synapticure

10/24/2025

Brain Computer Interfaces (BCI) has the chance to restore the little things we take for granted as healthy adults every day -- communication, moving a mouse, and hopefully someday replacing lost control of movement. We are grateful to host three patients in Neuralink's ALS trial for webinar on October 28th at 2PM ET with representatives from , and to build awareness for this and other upcoming clinical trials.

Register for the webinar here. https://synapticure.zoom.us/webinar/register/WN__a_f8PE-QTyr9FVJMNDk3w #/registration

Click the link above to register and connect with patients who are using Neuralink today to hear about their journey to BCI, their decision to join the trial, and how it has changed their lives. Please feel free to submit questions in advance in the registration link.

10/21/2025

Synapticure is excited to share that we will be hosting a webinar on 10/28 with participants in the Neuralink ongoing ALS trial, along with representatives from the company. The webinar will feature Brad Smith, Jake Schneider, and Nick Wray—three individuals with ALS participating in Neuralink’s clinical trials to explore the use of BCI technology in their daily lives.

In the webinar we will discuss the technology, the decisions patients make to participate in studies around BCI technology, and connect with patients who have enrolled in the study and are using Neuralink today. To register for the Webinar, click here.

We hope to see you on the 28th! Register here to attend, ask questions and / or receive the recording.

https://synapticure.zoom.us/webinar/register/WN__a_f8PE-QTyr9FVJMNDk3w

10/03/2025

Synapticure’s Clinical Research team, led by Abigail O’Connell and Eric Anderson, is excited to join the NEALS Annual Conference next week in Clearwater, Florida October 7-10th!

We’re looking forward to connecting with colleagues and collaborators to discuss how Synapticure is expanding remote access to research participation for people living with ALS—helping patients enroll and stay engaged in trials regardless of where they live.

We’ll also be presenting a poster with our colleagues at Clene Nanomedicine and Jinsy Andrews:
“A Comparison of Baseline Clinical Characteristics Between Decentralized and Institutionally-Enrolled Participants in the CNM-Au8 EAP04 Study”

If you’ll be at NEALS, we’d love to connect—whether to discuss partnerships, share insights, or explore how we can work together to bring more inclusive research opportunities to ALS patients everywhere.

Reach out to partners@synapticure.com for more information or to schedule a meeting

09/09/2025

We’re thrilled to share that our CEO & Co-Founder, Sandra Abrevaya, will be a featured keynote speaker at the New York Brain-Computer Interface Symposium ( ) on October 3-4 in New York City!

Sandra will present “The Power of Advocacy: Driving BCI Forward,” highlighting how patient voices and advocacy guide research, shape policy, and keep people at the center of innovation.

We’re honored to be part of this global conversation and can’t wait to share what’s ahead in .

08/28/2025

From virtual visits with leading specialists to wraparound care, medication management, genetic testing, counseling, and access to clinical trials— we make expert care neurology available all from the comfort of your home.

Learn more at synapticure.com or call (855) 255-5917

08/26/2025

Curious about genetic testing? You’re not alone.

Our experts break it down in clear, easy-to-follow blogs covering what it is, how it works, & why it's so important.

Want to know if genetic testing is right for you? Call (855) 255-5917 to schedule a call with our experts.

Read more here: https://www.synapticure.com/blog

08/21/2025

From one family’s journey to a national movement— our latest blog shares the story behind our mission and the care model we've built to support millions of families across country.

Read the full story here → https://www.synapticure.com/blog/synapticures-origin-story-our-mission-milestones-and-impact

After an ALS diagnosis at 37, Brian Wallach and Sandra Abrevaya founded Synapticure to fix a broken system. Learn how their personal story became a national model for virtual neurodegenerative care.

08/19/2025

Every person living with ALS carries a story of resilience—and every caregiver, a story of love and devotion. At Nexus, we were reminded why this work matters. From our Chief Medical Officer, Dr. Eric Anderson, highlighting the vital role of caregivers, to sharing our work to enable the first fully-remote for , Synapticure was proud to sponsor and stand alongside a community that refuses to give up on better care, better treatments, and a better future.

08/11/2025

10,000 psychologists. One massive conference. And Synapticure on stage.

Last week in Denver, Dr. Tracey Meyers presented our latest Collaborative Care Model (CoCM) data at the American Psychological Association’s Annual Conference— showing clinicians from around the world how our approach is improving quality of life and lowering rates of depression and anxiety for people living with neurodegenerative diseases and their families.

Learn more about our study: https://vist.ly/322rp

08/04/2025

Mark your calendars! Chief Medical Officer Dr. Eric Anderson is speaking at The ALS Association. ALS Nexus Conference, joining a powerful conversation on one of the most over-looked forces in ALS care: family caregivers.

His panel, Essential Partners: Elevating the Role of ALS Caregivers in Clinical Care, Advocacy, and Research, will dive into the practical, systemic, and deeply human ways we can better support caregivers— not just as helpers, but as central partners in driving better outcomes for people living with ALS.

From research to policy, and clinic visits to daily decisions, this session will explore how to make caregiving more sustainable, inclusive, and impactful.

Learn more: https://vist.ly/328qv

08/01/2025

What do you get when you mix bold ideas, neuroscience, and a whole lot of brainpower? A week at with our team 😄🧠

We had a blast at the Alzheimer's Association International Conference sharing what we’ve been working on and learning from so many others pushing the boundaries in Alzheimer’s research and care delivery.

Huge shoutout to our team member Dr. Jeremy Pruzin who took the stage to share a new clinical trial proposal on behalf of Banner Health and made us proud.

There’s a lot of work to be done in 's care and research and we’re excited to help move it forward!

Pictured: Eric Anderson, Peter Wallach, Jeremy Pruzin, Abigail O'Connell

07/30/2025

We’re thrilled to share that Synapticure has been awarded the Hoffman ALS Clinic Capacity Award by the The ALS Association to expand access to expert, multidisciplinary ALS care through telemedicine.

This inaugural grant program aims to close care gaps nationwide by supporting clinics that deliver high-quality, team-based care proven to improve quality of life and extend survival for people living with .

We’re honored to help bring this standard of care into more homes across the country.

Thank you to the The ALS Association and the Hoffman family for your commitment to transforming ALS care.

Read the full release: https://vist.ly/3zkup

/PRNewswire/ -- The ALS Association announced inaugural recipients of the Hoffman ALS Clinic Development and Capacity Awards, new grant programs established to...